Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Temsirolimus with chemotherapy for high-risk neuroblastoma
NCT00808899Phase 2Terminated
- Sponsor
- St. Jude Children's Research Hospital
- Start
- Dec 2008
- Primary completion
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of temsirolimus in neuroblastoma, sponsored by St. Jude Children's Research Hospital. Started Dec 2008; status: terminated.
02
Drugs
temsirolimus
03
Conditions
neuroblastoma
Beyond the preview
Go deeper on NCT00808899.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00808899.